Both diffuse lower grade gliomas (LGGs) and glioblastomas (GBMs) are further subdivided into IDH-mutant and IDH-wildtype based on the presence or absence of isocitrate dehydrogenase gene 1 or 2 (IDH1/2) mutation. This evidence concerns the gene IDH1 and glioblastoma.